4gr9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation== | ==Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation== | ||
<StructureSection load='4gr9' size='340' side='right' caption='[[4gr9]], [[Resolution|resolution]] 2.29Å' scene=''> | <StructureSection load='4gr9' size='340' side='right'caption='[[4gr9]], [[Resolution|resolution]] 2.29Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4gr9]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4gr9]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GR9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GR9 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=372:N-[(3R)-3-(CYANOMETHYL)-1-METHYL-2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL]ACETAMIDE'>372</scene>, <scene name='pdbligand=FAD:FLAVIN-ADENINE+DINUCLEOTIDE'>FAD</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=372:N-[(3R)-3-(CYANOMETHYL)-1-METHYL-2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL]ACETAMIDE'>372</scene>, <scene name='pdbligand=FAD:FLAVIN-ADENINE+DINUCLEOTIDE'>FAD</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gr9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gr9 OCA], [https://pdbe.org/4gr9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gr9 RCSB], [https://www.ebi.ac.uk/pdbsum/4gr9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gr9 ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/NQO2_HUMAN NQO2_HUMAN] The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.<ref>PMID:18254726</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 21: | Line 18: | ||
</div> | </div> | ||
<div class="pdbe-citations 4gr9" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4gr9" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Quinone reductase|Quinone reductase]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Jensen | [[Category: Large Structures]] | ||
[[Category: Lozinskaya | [[Category: Jensen KC]] | ||
[[Category: Mesecar | [[Category: Lozinskaya NA]] | ||
[[Category: Proskurnina | [[Category: Mesecar AD]] | ||
[[Category: Sosonyuk | [[Category: Proskurnina MV]] | ||
[[Category: Volkova | [[Category: Sosonyuk SE]] | ||
[[Category: Zefirov | [[Category: Volkova MS]] | ||
[[Category: Zefirov NS]] | |||
Revision as of 07:12, 26 October 2022
Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation
| ||||||||||||